Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran
EMHJ-Eastern Mediterranean Health Journal. 2006; 12 (5): 548-554
in English
| IMEMR
| ID: emr-156910
ABSTRACT
We examined the therapeutic effects of albendazole compared to metronidazole in 120 patients with giardiasis in Hamdan. Patients were randomized to receive albendazole [400 mg, once daily for 5 days] or metronidazole [250 mg, 3 times a day for 5 days]. Demographic data of the patients, results of stool for Giardia trophozoites before and after treatment, and drug side- effects were recorded. After treatment 6 [10.0%] of the albendazole group had trophozoites compared with 14 [23.3%] of metronidazole group [P < 0.05]. Patients in the albendazole group had fewer side- effects while 43.3% of the metronidazole group experienced a metallic taste and 35.0% experienced loss of appetite. Albendazole is an easy, safe and effective treatment for giardiasis
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Albendazole
/
Feces
/
Metronidazole
Type of study:
Controlled clinical trial
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Language:
English
Journal:
East Mediterr Health J.
Year:
2006
Similar
MEDLINE
...
LILACS
LIS